Hypertension Management Guidelines
The management of hypertension requires a combination of lifestyle modifications and pharmacological therapy, with a target blood pressure of <130/80 mmHg for most adults to reduce morbidity and mortality from cardiovascular events 1.
Diagnosis and Evaluation
Blood Pressure Measurement
- Patient should be seated with arm at heart level
- Use properly calibrated device with appropriate cuff size
- Take at least two measurements at each visit
- Consider ambulatory blood pressure monitoring (ABPM) for:
- Unusual BP variability
- Resistant hypertension (≥3 drugs)
- Suspected white coat hypertension
- Symptoms suggesting hypotension 2
Initial Evaluation
- Routine investigations for all hypertensive patients:
- Urine test for blood and protein
- Blood electrolytes and creatinine
- Blood glucose
- Serum total:HDL cholesterol ratio
- 12-lead ECG 2
Treatment Thresholds
Immediate drug treatment for:
Consider drug treatment for:
- Sustained systolic BP 140-159 mmHg or diastolic BP 90-99 mmHg with:
- Target organ damage
- Established cardiovascular disease
- Diabetes
- 10-year cardiovascular disease risk ≥20% 2
- Sustained systolic BP 140-159 mmHg or diastolic BP 90-99 mmHg with:
Blood Pressure Targets
- General target: <130/80 mmHg for most adults 1
- Higher risk populations (diabetes, renal impairment, established cardiovascular disease): ≤130/80 mmHg 1
- Minimum acceptable control (audit standard): <150/90 mmHg 2
Non-Pharmacological Management
All patients with hypertension should receive advice on lifestyle modifications:
- Weight reduction to achieve ideal body weight
- Physical activity: Regular dynamic exercise (e.g., brisk walking)
- Dietary modifications:
- Alcohol limitation: <21 units/week for men, <14 units/week for women 2
- Smoking cessation 2, 1
These lifestyle modifications can reduce blood pressure significantly and may reduce the need for medication or allow lower doses 4.
Pharmacological Management
First-Line Therapy
- For most patients without compelling indications:
Special Populations
- Patients with diabetes and albuminuria/proteinuria:
- ACE inhibitors preferred 1
- Black patients:
- ARB + dihydropyridine CCB or dihydropyridine CCB + thiazide-like diuretic 1
- Patients with stage 2 hypertension (≥160/100 mmHg):
- Consider combination therapy with ACE inhibitor/ARB and calcium channel blocker or diuretic 1
Treatment Escalation
- Start with monotherapy for mild hypertension
- If BP not controlled, use two-drug combination
- If BP still not controlled, progress to three-drug combination: RAS blocker + CCB + thiazide diuretic 1
- For resistant hypertension, add spironolactone as fourth-line agent 1
Important Considerations and Cautions
Avoid combining ACE inhibitors with ARBs - increases adverse effects without additional benefit 1
Monitor for orthostatic hypotension, especially in older patients 1
Contraindications:
Follow-up:
- Within 2-4 weeks after starting or changing medications
- Check serum creatinine and potassium 7-14 days after initiating ACE inhibitors/ARBs 1
Indications for Specialist Referral
- Urgent treatment needed:
- Malignant hypertension
- Severe hypertension (>220/120 mmHg)
- Impending complications (TIA, left ventricular failure)
- Suspected secondary hypertension
- Resistant hypertension (≥3 drugs)
- Young age (<30 years needing treatment)
- Pregnancy 2
Effective implementation of these guidelines requires a systematic approach, patient education, and regular monitoring to ensure optimal blood pressure control and reduction of cardiovascular risk.